News & Updates
Showing Multidisciplinary articles
Showing
Dapagliflozin improves symptoms, physical limitations in HFpEF
Patients with heart failure and preserved ejection fraction (HFpEF) treated with dapagliflozin experienced improvements in symptoms and physical limitations, according to results of the PRESERVED-HF study presented at HFSA 2021.
Tocilizumab cuts COVID-19 mortality when administered during the early inflammatory stage
Tocilizumab does not seem to prevent the progression of the coronavirus disease 2019 (COVID-19) to critical disease but may still be valuable in severely ill patients when used during the early inflammatory stages, a recent study has found.
Cilostazol makes good in DAPT for recurrent stroke prevention in high-risk patients
Dual antiplatelet therapy (DAPT) with cilostazol performs better than either aspirin or clopidogrel alone at reducing the risk of recurrent stroke or vascular events without increasing the incidence of bleeding for patients with ischaemic stroke and intracranial arterial stenosis, according to the results of the CSPS.com* trial.
Wheat bran with RPS boosts serum SCFAs in obese people without improving health parameters
Consumption of wheat bran (WB) with reduced particle size (RPS) increases concentrations of fasting serum short-chain fatty acid (SCFA) in obese individuals, a study has shown. Such changes, however, do not appear to have beneficial effects on health parameters.
Fructose from fruit juice, SSBs tied to higher liver fat content
The consumption of fructose from fruit juice and sugar sweetened beverages (SSBs), but not from fruit, is associated with higher intrahepatic lipid (IHL) content, according to data from a cross-sectional study presented at EASD 2021.
Gene mutations may provide clues for liver cancer survival
Recent research has found that mutations in the human EZH2 and CCND1 genes may be potential novel biomarkers for liver cancer. The tumour mutation burden (TMB) also appears to be an important prognostic factor and affects patient survival.
